超声新技术对甲状腺功能亢进引起心脏及肝脏损害的评价
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:应用超声脉冲多普勒(PW)、组织多普勒成像(TDI)联合技术评价甲亢性心脏病(简称甲亢心)右室功能。
     方法:选取60例甲状腺功能亢进(简称甲亢)患者,根据是否并发甲亢心分为单纯甲亢组(37例)和甲亢心组(23例),并选取30例正常人为对照组,应用PW测量三尖瓣口舒张期峰值血流速度E峰;应用TDI于心尖四腔切面三尖瓣环间隔处和侧壁处测量收缩期峰值速度(Sm)、舒张期峰值速度(Em),并计算E/Em。
     结果:⑴与对照组比较,单纯甲亢组侧壁处Sm增高,两组之间差异有统计学意义(P﹤0.05),甲亢心组侧壁处Sm较单纯甲亢组差异有统计学意义(P﹤0.05);⑵甲亢心组侧壁处Em减低,较对照组差异有统计学意义(P﹤0.05);⑶单纯甲亢组侧壁处E/Em与对照组之间差异无统计学意义(P﹥0.05),而甲亢心组较对照组E/Em明显增高,两组之间差异有统计学意义(P﹤0.05)。
     结论:PW与TDI联合应用可以较为准确地评价甲亢心患者右室功能。
     目的:探讨超声背向散射积分参数(IBS)在评价甲状腺功能亢进(甲亢)导致肝脏损害方面的临床应用价值。
     方法:实验组为60例甲亢患者(未经药物治疗),分为单纯性甲亢组(29例肝生化正常患者),甲亢性肝损害组(31例肝功能指标异常患者),对照组为50例健康成人。对三组受试者肝脏进行超声IBS参数测定,同时所有受检者均静脉采血进行甲状腺功能及肝功能指标测定。
     结果:实验组肝脏IBS及IBS%均较对照组显著增高(P<0.01);甲亢性肝损害组中出现肝脏损伤较单纯甲亢组未出现肝脏损伤者肝脏IBS及IBS%增高(P<0.05);相关分析示游离四碘甲状腺原氨酸(FT4)与谷丙转氨酶(ALT)、碱性磷酸酶(ALP)呈正相关(r1=0.501、r2=0.558, P<0.05)。肝脏IBS%与ALP、ALT、FT4均呈正相关(r1=0.702、r2=0.617、r3=0.604,P<0.05)。
     结论:超声背向散射积分参数可以定量评价甲状腺功能亢进所致的肝脏损害,尤其是对肝脏的早期损伤的评价较临床更为敏感。
Objective:To evaluate the right ventricular function in patients with hyperthyroid cardiopathy by pulse ultrasonic wave Doppler technique (PW) and Tissue Doppler imaging (TDI).
     Methods: Sixty patients having hyperthyroidism,whether they have hyperthyroid cardiopathy or not divided into simple hyperthyroidism group(n=37) and hyperthyroid cardiopathy group(n=23).Thirty normal volunteers served as control group.Tricuspid inflow velocity(E) was measured by Doppler echocardiography;TDI-derived systolic tricuspid annular velocity(Sm),diastolic tricuspid annular velocity(Em),the ratio of diastolic tricuspid inflow velocity to Em (E/Em) was caculated.
     Results:①Compared with control group,Sm was higher in simple hyperthyroidism group(P﹤0.05),Compared with simple hyperthyroidism group, Sm was lower in cardiopathy group(P﹤0.05).②Compared with control group,Em of tricuspid annular lateral wall was lower in hyperthyroid cardiopathy group(P﹤0.05).③The E/Em ratio in hyperthyroid cardiopathy group was significantly higher than that in control group(P﹤0.05),however there were no significant differences between simple hyperthyroidism group and control group(P﹤0.05).
     Conclusion:PW and TDI can exactly evaluate right ventricular function in patients with hyperthyroid cardiopathy.
     Objective: To evaluate the clinical value of integrated backscatter(IBS) parameters in hyperthyroidism with hepatic dysfunction.
     Methods: Sixty patients having hyperthyroidism haven’t take medicine yet divided into normal Liver biochemical group(n=29)and abnormal Liver biochemical group(n=31).Fifty volunteers without liver diseases(control group).Integrated backscatter parameters were detected by ultrusound.Thyroid and liver function parameter were measured by vascular blood.
     Results: IBS and IBS% were significantly higher in the experimental group than those in the control group (P<0.01) .IBS and IBS% in abnormal Liver biochemical group was higher than that in normal Liver biochemical group(P﹤0.05).Correlation analysis:there is positive correlation between FT4 and ALP,ALT(r1=0.501、r2=0.558,P<0.05).IBS% is positive correlation with ALP,ALT,FT4.(r1=0.702、r2=0.617、r3=0.604,P<0.05).
     Conclusion: Integrated backscatter parameters may be valuable in the assessment of hyperthyroidism with hepatic dysfunction,especially in the assessment of early damage.
引文
1.宣变兰,杨兴政.131碘治疗甲状腺功能亢进性心脏病6O例临床分析.实用医技杂志,2009,16(4):299-300.
    2.林丽香.甲亢的心血管系统表现及其处理.中国实用内科杂志,1997,17(12):708-710.
    3.徐爱华,高万,曾志红.200例甲亢性心脏病的临床类型与特征.医师进修杂志,1994,17(2):25-26.
    4.The Criteria Committee of the New York Heart Association.Nomenclature and criteria for diagnosis of disease of the heart and great vessels.9th ed.Boston: Little,Bron and Co,1994,2(5):25-29.
    5.肖琳玲,谌承志,邓万俊,等.组织多普勒超声显像评价室壁运动与心功能的新进展.医学综述,2007,13(2):148-150.
    6.李文静,张木勋,欧阳金枝.甲亢性心脏病68例入院时临床特点分析.内科急危重症杂志,2003,9(4):194-195.
    7.王海鱼,陈金华,夏斌赞.小剂量甲状腺素治疗慢性充血性心力衰竭伴低T3、T4综合征的临床研究.实用医学杂志,2005,21(3):271-272.
    8.刘宏娟.甲状腺功能亢进性心脏病46例临床分析.承德医学院学报,2007,24(4):435-436.
    9.张文华,夏稻子,张宇虹,等.组织多普勒成像对正常成人左、右心功能对比观测.心脏杂志,2010,22(3):430-432.
    10.叶岚,周长钰,蔡金荣,等.心脏舒张功能新指标E/Em的影响因素分析.中国超声医学杂志,2007,23(8):587-589.
    11.Ommen SR,Nishimura RA,Appleton CP,et al.Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures,A comparative simultaneous Doppler-catheterization study. Circulation, 2000,102(15):1788-1794.
    12.曾欣,舒先红,何梅先,等.多普勒组织成像评价左室整体功能的最佳部位的选择.中国超声医学杂志,2002,18(2):105-107.
    1.白耀.甲状腺功能亢进与其他内科疾病.甲状腺病学-基础与临床.北京:科学技术文献出版社,2003:389-391.
    2.张晓霞.503例甲亢性肝损害患者的临床分析.标记免疫分析与临床,2004,11(3):145-147.
    3.Fong TL,MeHutehinson J G,Reynolds TB.Hyperthyroidism and hepatic dysfunction.A ease series analysis.J Clin Gastroenterol,1992,14(3):240-244.
    4.吴作艳,王炳元.甲亢性肝损害.中国实用内科杂志,2002,22(5):311-312.
    5.Videla LA,Somk G,Troncaso P,et al.Influence of hyperthyroidism on lindane-induced hepatoto- xicity in the rat.Biochem Pharmacol,1995,50(10):1557-1565.
    6.Anton Aranda E.Intrahepatic cholestasis in untreated hyperthyroidism.Rev Esp Enferin Dig,2000, 92(1):49-52.
    7.Viallard JF,Tabarin A,Neau D,et al.Hyperthyroidism with severe intrahepatic Cholestasis.Dig Dis Sci,1999,44(10):2001-2002.
    8.曹小玲,卢岷,冉海涛,等.超声背向散射积分对肝脏纤维化诊断价值的初步研究.临床超声医学杂志,2003,5(1):220-222.
    9.Hoyt RH,Collins SM,Skorton DJ,et al.Assessment of fibrosis in infracted human hearts by analysis of ultrasonic backscatter.Circulation,1985,71(4):740-744.
    10.张涛,游金辉.甲亢性肝功能损害及其相关因素.华西医学,2004,19(3):395-396.
    11.娄霞英.甲状腺功能亢进症伴肝损59例临床分析.上海预防医学杂志,2002,14(7):304-305.
    12.段敏虹,陈广原,张彤.甲状腺功能亢进症患者肝功能变化的相关因素分析.中国医师进修杂志(内科版),2006,29(6):53-54.
    1.宣变兰,杨兴政.131碘治疗甲状腺功能亢进性心脏病60例临床分析.实用医技杂志,2009,16(4):299-300.
    2.叶任高,陆再英.内科学[M]第六版.北京:人民卫生出版社,2004.728-732.
    3.徐爱华,高万,曾志红.200例甲亢性心脏病的临床类型与特征.医师进修杂志,1994,17(6):25-27.
    4.陈永生.甲状腺功能亢进性心脏病81例临床分析.中国实用医药,2008,3(24):74-75.
    5.张希德.内科临床思维[M].北京:科学出版社,2000.529-536.
    6.Waggoner AD,Bieriq SM.Doppler tissue imaging:A useful echooardiac sonographic method for the cardiac sonographer to assess systolic and diastolic ventricular function.J Am Soc Echocardioqr,2001,14(12):1143-1152.
    7.Ommen SR,Shimura RA,Appleton CP,et a1.Clinical utility of Doppler echocardiography and tissue doppler imaging in the estimation of left ventricular filling pressures:A comparative simultaneous doppler catheterization study.Circulation,2000,102(15):1788-1794.
    8.李靖,刘延玲,吕秀章,等.多普勒组织成像鉴别肥厚型心肌病舒张功能假性正常.中华超声影像学杂志,2004,13(1):28-28.
    9.宋则周,马静.组织速度成像评估特发性肺动脉高压患者右心室心肌非同步运动.中华超声影像学杂志,2006,15(10):738-740.
    10.Pacileo G,Paladini D,Russo MG,et al.Echocariographic assessment of ventricular filling pressure during the second and third trimesters of gestation.Ultrasound Obstet Gynecol, 2000, 16(2):128-132.
    11.McMahon CJ,Nahueh SF,Pihnatelli RH,et al.Characterization of left ventricular diastolic function by tissue doppler imaging and clinical status in children with hypertxophic cardiomyopathy.Circulation,2004,109(13):1756-1762.
    12.Redfield MM,Jaco6sen SJ,Burmett Jr,et al.Burden of systolic and diastolic ventricular dysfunction in the community:appxeciating the scope of heart failure epidemic. JM4A, 2003,289(2):194-202.
    13.Rakowski H,Appleton C,Chan KL,et al.Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography from the investigations of consensus on diastolic dysfuncfion.J Am Soc Echocardiography,1996,9(5):736-760.
    14.Sohn DW,Chai IE-I,Lee DJ,et al.Assessment of mural annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function.J Am Coll Cardiol, 1997, 30(2):474-480.
    15.Gaertner R,Louedec L.Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MT in rats.Prunier Fabrice,2002,283(1):H346-H352.
    16.Nagueh S,Middleton K,Koplen H,et al.Doppler tissue imaging:a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures.J Am Coll Cardiol,1997,30(6):1527-1533.
    17.Dokainish H,Zoghbi RYA,Lakkis NM,et al.Optimal noninvasive assessment of left ventricular filling pressures:a comparison of tissue Doppler echocardiography and B-type natriuretic peptidein patients with pulmonary artery catheters.Circulation,2004,109(20):2432-2439.
    18.Ommen SR,Nishimura RA,Appleton Cf,et a1.Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures.A comparative simultaneous Doppler-catheterization study.Circulation,2000,102(15):1788-1794.
    19.王金锐,刘志跃,杨敬英,等.心脏纤维环运动的二维和M型超声心动图观测.内蒙古医学杂志,1987,7(3):12-14.
    20.Vinereanu D,Khokhar A,Tweddel AC,et a1.Estimation of global left ventricular function from the velocity of longitudinal shortening.Echocardiography,2002,19(3):177-185.
    21.Alma M,Wardelle J,Andersson E,et al.Effects of first myocardial infarction on left ventricular systolic and diastolic function with the use of mural annular velocity determined by pulsed wave noppler tissue imaging.J Am Soc Echocardiography,2000,13(5):343-352.
    22.夏纪筑,高玉丽.脉冲组织多普勒成像评价正常成年人右心室功能.四川医学,2006,27(9):910-911.
    23.Ueti OM,Camargo.Assessment of right ventricular function with Doppler echocardiographic indices derived from tricuspid annular motion:comparison with radionulide angiography. Heart,2002,88(3):244-248.
    24.王少娜,宋莉莉.脉冲组织多普勒超声评估哮喘患儿右室功能变化的探讨.影像诊断与介入放射学,2007,16(4):162-163.
    25.Meluzin J,Spinarova L,Iiakala J,et al.Pulsed Doppler tissue imaging of the velocity of tricuspid annular systolic motion:a new,rapid,and noninvasive method of evaluating right ventricular systolic function.Eur Heart J,2001,22(4):340-348.
    26.Witte KK,Nikitin NP,De SilvaR,et al.Exercise capacity and cardiac function assessed by tissue Doppler imaging in chronic failure.Heart,2004,90 (10):1144-1150.
    27.费爱华,刘艳红,陈书艳,等.氯沙坦对高血压左室肥厚和左室舒张功能的影响.实用诊断与治疗杂志,2006,20(2):111-112.
    28.李先维,代晓捷,张向东.肥胖对老年高血压左室肥厚和左心功能的影响.实用诊断与治疗杂志,2007,21(2):119-120.
    29.The Criteria Committee of the New York Heart Association.Nomenclature and criteria for diagnosis of disease of the heart and great vessels.9th ed.Boston:Little,Bron and Co,1994,2(5):25-29.
    30.Kinugawa K,Yonekura K,Ribeiro RC,et al.Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertroph.Circ Res,2001,89(7):591-598.
    31.Pantos C,Malliopoulou V,Varonos DD,et al.Thyroid hormone and phenotypes of cardioprotection.Basic Res Cardiol,2004,99(2):101-102.
    32.Venditti P,De Rosa R,cigliano L,et a1.Role of nitric oxide in the functional to ische mia-reperfusion of heart mitochondria from hyperthyroid rats.Cell Mol Life Sci, 2004, 61(17):2244-2252.
    33.Sawin CT.Subclinical hyperthyroidism and atrial fibrillation.Thyroid,2002,12 (6):501-503.
    34.黄为昆,陈克俭,钟洪才,等.老年毒性结节性甲状腺肿的手术治疗.华南国防医学杂志,2002,16(6):28-29.
    35.Auer J,Berent R,Bber B.Subclinical thyroid dysfunction and the heart.Ann Intern Med, 2003, 339(10):865-866.
    36.Vilches AR,Lerman J.First degree atrio-ventricular block in acute thyrotoxicosis. Medicina, 2004,64(1):51-53.
    37.Shimizu T,Koide S,Noh JY,et a1.E-Iyperthyroidism and the management of atrial fibrillation.Thyroid,2002,12(6):489-493.
    38.李文静,张木勋,欧阳念枝.甲亢性心脏病68例入院时临床特点分析.内科急危重症杂志,2003,9(4):194-195.
    39.王海鱼,陈全华,夏斌赞.小剂量甲状腺素治疗慢性充血性心力衰竭伴低T3、T4综合症的临床研究.实用医学杂志,2005,21(3):271-272.
    40.林丽香.甲亢的心血管系统表现及其处理.中国实用内科杂志,1997,17 (12):708.
    41.刘宏娟.甲状腺功能亢进性心脏病46例临床分析.承德医学院学报,2007,24(4):435-436.
    1.Goens MB,Karr SS,Martin G.Cyclic variation of integrated ultrasound backscatter:normal and abnormal myocardial patterns in children. J Am Soc Echo,1996,9(5):616-621.
    2.Ernst H,Hahn ZG,Balzer T,et al.Color Doppler ultrasound of liver lesions:signal enhancement after intravenous injection of the ultrasound contrast agent:Levovist.J Clin Ultrasound,1996,24(1):31- 35.
    3.赵玉华,姚伟,陈兰芳,等.实物声学密度定量的初步探讨.中国超声医学杂志,1998,14(7):123.
    4.陈宇翔,钱蕴秋,周小东,等.背向散射积分超声组织定征识存活心肌的实验.中华超声影像学杂志,1999,8(2):122-125.
    5.臧福波,高晓军.正常成人肝脏超声背向散射积分的测定.中华超声影像学杂志,2001,10(6):328-330.
    6.谢建华,袁博,赵夏夏,等.正常成人肝脏背向散射积分超声组织定征测定.西北国防医学杂志,2004,25(2):109-111.
    7.Adams LA,Talwalker JA.Diagnostic evaluation of nonalcoholic fatty liver disease.J Clin Gastroenterol,2006,40(s1):s34-38.
    8.王吉耀.脂肪肝临床流行病学.中华肝脏病杂志,2000,8(2):115-116.
    9.周永昌,郭万学,超声医学[M].第3版.北京:科学技术文献出版社.1998:369-371.
    10.卓忠雄,高云华,李宁,等.化疗性脂肪肝的超声组织定征研究.中华超声影像学杂志,2001,10(6):331-333.
    11.贾春梅,康春松,刘素香.均匀性脂肪肝的超声组织定征研究.中国超声医学杂志,2002,18(12):938-940.
    12.臧福波,高晓军,闻月异,等.肝硬化患者肝脏超声背向散射积分的应用研究.中华超声影像学杂志,2002,11(9):566-570.
    13.曹小玲,卢岷,冉海涛,等.超声背向散射积分对肝脏纤维化诊断价值的初步研究.临床超声医学杂志,2003,4(5):220-222.
    14.张立敏,富维强,任卫东,等.超声背向散射积分定量评价大鼠肝纤维化及肝硬化.中国医学影像技术,2006,22(2):209-211.
    15.高晓军,臧福波,闻月异.超声背向散射积分在肝占位性病变诊断中的应用价值.中国超声医学杂志,2004,1(20):46-49.
    16.Leeuwenburgh I,Stijnen PJ,Verburg GP.Recovery of chronic hepatitis by treatment of concomitant hypesthyroidism-Eur J Gastroenterol Hepatol,2001,13(11):1389-1392.
    17.Majeed M.Babu A.Cholestasis secondary to hyperthyroidism made worse by methimazol.Am JMed Sci,2006,332(1):51-53.
    18.Malik R,Hodgson H.The relationship between the thyroid gland and the liver. Quarterly Journal of Medicine,2002,95(9):559-569.
    19.Mikhail NE.Methimazole-induced cholestatic jaundice.South M ed J,2004,97(2):178-182.
    20.Fong TL,MeHutehinson J G,Reynolds TB.Hyperthyroidism and hepatic dysfunction.A ease series analysis.J Clin Gastroenterol,1992,14(3):240-244.
    21.吴作艳,王炳元.甲亢性肝损害.中国实用内科杂志,2002,22(5):311-312.
    22.Videla LA,Somk G,Troncaso P,et al.Influence of hyperthyroidism on lindane-induced heaptotox- icity in the rat.Biochem Pharmacol,1995,50(10):1557-1565.
    23.Anton Aranda E.Intrahepatic cholestasis in untreated hyperthyroidism.Rev Esp Enferin Dig,2000, 92(1):49-52.
    24.Viallard JF,Tabarin A,Neau D,et al.Hyperthyroidism with severe intrahepatic Cholestasis.Dig Dis Sci,1999,44(10):2001-2002.
    25.白耀.甲状腺功能亢进与其他内科疾病.甲状腺病学-基础与临床.北京:科学技术文献出版社,2003:389-391.
    26.张晓霞.503例甲亢性肝损害患者的临床分析.标记免疫分析与临床,2004,11(3):145-147.
    27.由悦,张文华,夏稻子.超声背向散射积分对甲亢性肝病及脂肪肝所致肝功能损害的诊断价值.中国内科实用杂志,2010,1(30):18-19.
    28.陈宇翔,钱蕴秋,李军,等.正常心肌背向散射积分超声组织定征.中国医学影像学杂志,2001,8(1):45-47.
    29.Castaldo M,Funaro S,Veneroso G,et al.Detection of residual tissue viability within the infarct zone in patients with acute myocardial infarction: ultrasonic integrated backscatter analysis versus dobutamine stress echocardiography.Journal of the American Society of Echocardiography, 2000, 13(5):358-367.
    30.Mizuno R,Fujimoto S,Yamaji K,et al.Myocardial ultrasonic tissue characterization for estimating histological abnormalities in hypertrophic cardiomyopathy:comparison with endomyocardial biopsy findings.Cardiology, 2001, 96(1):16-23.
    31.Onbasili OA,Tekten T,Ceyhan C,et al.Ultrasonic integrated backscatter analysis in patients with dilated cardiomyopathy:comparison with healthy individuals.Anadolu Kardiyol Derg,2002, 2(1): 4-11.
    32.Suwa M,Into T,Nakamara T,et al.Prognostic implications derived from ultrasonic tissue characterization with myocardial integrated backscatter in patients with dilated cardiomyopathy .International Journal of Cardiology,2002,8(4):133-140.
    33.Mizushige K,Tokudome T,Seki M,et al.Sensitive detection of myocardial contraction abnormalityin chronic hemodialysis patients by ultrasonic tissue characterization with integrated backscatter. Angiology,2000,51(3):223-230.
    34.Recchia D,Wickline SA.Ultrasonic tissue characterization of blood during stasis and thrombosis with a real-time linear-array backscatter imaging system.Coron Artery Dis,1993,4(11):987-994.
    35.顾再荣,李军,陈翔宇.背向散射积分超声组织定征在尿毒症监测中的初步应用.中华超声影像学杂志,1998,7(4):220-222.
    36.李英梅,夏稻子,马秀丽,等.正常成人胰腺超声背向散射积分的测定.中国超声医学杂志,2006,22(1):41-43.
    37.Hall CF,Verdonk ED,Wickline SA,et al.Anisotropy of the apparemt frequency dependence of backscatter in formalin fixed human my ocardium.J Aacoustic soc Am,1997,101(1):563-568.
    38.Ota T,Craia DM,Kisslo J.Influences of ultrasonic machine settings,transducer frequency and placement of region of interest on the measurement of integrated backscatter and cyclic variation .Ultrasound in Med & biol,1997,23(7):1059-1070.